M, B., Y, S., E, H., P, K., & G, S. (2013). Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro. Clinical cancer research : an official journal of the American Association for Cancer Research, 19(18), 5092. https://doi.org/10.1158/1078-0432.CCR-12-2211
Chicago Style (17th ed.) CitationM, Burmakin, Shi Y, Hedström E, Kogner P, and Selivanova G. "Dual Targeting of Wild-type and Mutant P53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells in Vivo and in Vitro." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19, no. 18 (2013): 5092. https://doi.org/10.1158/1078-0432.CCR-12-2211.
MLA (9th ed.) CitationM, Burmakin, et al. "Dual Targeting of Wild-type and Mutant P53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells in Vivo and in Vitro." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 19, no. 18, 2013, p. 5092, https://doi.org/10.1158/1078-0432.CCR-12-2211.